Paradiem LLC Makes New $936,000 Investment in Linde PLC $LIN

Paradiem LLC purchased a new position in Linde PLC (NASDAQ:LIN) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 1,971 shares of the basic materials company’s stock, valued at approximately $936,000.

Several other hedge funds also recently made changes to their positions in the stock. Darwin Wealth Management LLC bought a new position in Linde in the 2nd quarter worth about $25,000. eCIO Inc. bought a new position in shares of Linde in the first quarter valued at approximately $45,000. Howard Hughes Medical Institute purchased a new position in Linde during the second quarter valued at approximately $48,000. Nova Wealth Management Inc. bought a new stake in Linde during the 1st quarter worth approximately $52,000. Finally, Activest Wealth Management lifted its stake in Linde by 5,800.0% in the 1st quarter. Activest Wealth Management now owns 118 shares of the basic materials company’s stock worth $55,000 after purchasing an additional 116 shares in the last quarter. 82.80% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on LIN. Seaport Res Ptn upgraded shares of Linde from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 3rd. BMO Capital Markets set a $501.00 price objective on Linde in a research note on Wednesday, December 17th. UBS Group restated a “buy” rating on shares of Linde in a research report on Friday, December 12th. Mizuho set a $495.00 price target on Linde in a report on Thursday, December 11th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $516.00 price target on shares of Linde in a research report on Monday, November 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Linde has a consensus rating of “Buy” and a consensus price target of $501.00.

Linde Stock Down 0.0%

Shares of NASDAQ:LIN opened at $424.77 on Friday. The firm has a market capitalization of $198.35 billion, a PE ratio of 28.45, a price-to-earnings-growth ratio of 3.26 and a beta of 0.85. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.69 and a current ratio of 0.82. Linde PLC has a 52-week low of $387.78 and a 52-week high of $486.38. The firm has a fifty day moving average of $419.51 and a 200 day moving average of $452.44.

Linde (NASDAQ:LIN) last released its quarterly earnings results on Friday, October 31st. The basic materials company reported $4.21 earnings per share for the quarter, beating analysts’ consensus estimates of $4.18 by $0.03. Linde had a return on equity of 19.38% and a net margin of 21.17%.The business had revenue of $8.62 billion for the quarter, compared to the consensus estimate of $8.62 billion. During the same quarter last year, the business posted $3.94 earnings per share. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. Linde has set its FY 2025 guidance at 16.350-16.450 EPS and its Q4 2025 guidance at 4.100-4.200 EPS. As a group, research analysts anticipate that Linde PLC will post 16.54 EPS for the current fiscal year.

Linde Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 17th. Investors of record on Wednesday, December 3rd were given a $1.50 dividend. The ex-dividend date was Wednesday, December 3rd. This represents a $6.00 dividend on an annualized basis and a yield of 1.4%. Linde’s payout ratio is presently 40.19%.

Linde Profile

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher?value specialty and electronic gases.